Internal exposure of the general population to DEHP and other phthalates--determination of secondary and primary phthalate monoester metabolites in urine
- PMID: 12963402
- DOI: 10.1016/s0013-9351(03)00083-5
Internal exposure of the general population to DEHP and other phthalates--determination of secondary and primary phthalate monoester metabolites in urine
Abstract
A number of phthalates and their metabolites are suspected of having teratogenic and endocrine disrupting effects. Especially the developmental and reproductive effects of di(2-ethylhexyl)phthalate (DEHP) are under scrutiny. In this study we determined the concentrations of the secondary, chain oxidized monoester metabolites of DEHP, mono(2-ethyl-5-hydroxyhexyl)phthalate (5OH-MEHP) and mono(2-ethyl-5-oxo-hexyl)phthalate (5oxo-MEHP) in urine samples from the general population. The utilization of the secondary metabolites minimized any risk of contamination by the ubiquitously present phthalate parent compounds. Included in the method were also the simple monoester metabolites of DEHP, dioctylphthalate (DOP), di-n-butylphthalate (DnBuP), butylbenzylphthalate (BBzP) and diethylphthalate (DEP). Automated sample preparation was performed applying a column switching liquid chromatography system enabling online extraction of the urine on a restricted access material (RAM) and separation on a reversed phase analytical column. Detection was performed by negative ESI-tandem mass spectrometry in multiple reaction monitoring mode and quantification by isotope dilution. The excretion of DEHP and the other phthalates was studied by analyzing first morning urine samples from 53 women and 32 men aged 7-64 years (median: 34.2 years) living in northern Bavaria (Germany) who were not occupationally exposed to phthalates. Phthalate metabolites, secondary and primary ones, were detected in all specimens. Concentrations were found to vary strongly from phthalate to phthalate and subject to subject with differences spanning more than three orders of magnitude. Median concentrations for excretion of DEHP metabolites were 46.8 microg/L for 5OH-MEHP (range 0.5-818 microg/L), 36.5 microg/L for 5oxo-MEHP (range 0.5-544 microg/L), and 10.3 microg/L for MEHP (range:<0.5 (limit of quantification, LOQ) to 177 microg/L). A strong correlation was found between the excretion of 5OH-MEHP and 5oxo-MEHP with a correlation coefficient of r=0.991, indicating close metabolic proximity of those two parameters but also the absence of any contaminating interference. Median concentrations for the other monoester metabolites were for mono-n-butylphthalate (MnBuP) 181 microg/L, for monobenzylphthalate (MBzP) 21.0 microg/L, for monoethylphthalate (MEP) 90.2 microg/L and for mono-n-octylphthalate (MOP)<1.0 microg/L (LOQ). These results will help to perform health risk assessments for the phthalate exposure of the general population.
Similar articles
-
On-line clean-up by multidimensional liquid chromatography-electrospray ionization tandem mass spectrometry for high throughput quantification of primary and secondary phthalate metabolites in human urine.J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jan 25;784(1):169-82. doi: 10.1016/s1570-0232(02)00785-7. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 12504195
-
An estimation of the daily intake of di(2-ethylhexyl)phthalate (DEHP) and other phthalates in the general population.Int J Hyg Environ Health. 2003 Mar;206(2):77-83. doi: 10.1078/1438-4639-00205. Int J Hyg Environ Health. 2003. PMID: 12708228
-
Biological monitoring of the five major metabolites of di-(2-ethylhexyl)phthalate (DEHP) in human urine using column-switching liquid chromatography-tandem mass spectrometry.J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Feb 25;816(1-2):269-80. doi: 10.1016/j.jchromb.2004.11.048. J Chromatogr B Analyt Technol Biomed Life Sci. 2005. PMID: 15664359
-
Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure-- an update and latest results.Int J Androl. 2006 Feb;29(1):155-65; discussion 181-5. doi: 10.1111/j.1365-2605.2005.00607.x. Int J Androl. 2006. PMID: 16466535 Review.
-
Di (2-ethyl hexyl) phthalate and its metabolite-induced metabolic syndrome: a review of molecular mechanisms.Drug Chem Toxicol. 2025 Mar;48(2):325-343. doi: 10.1080/01480545.2024.2405830. Epub 2024 Sep 25. Drug Chem Toxicol. 2025. PMID: 39322993 Review.
Cited by
-
Associations among phthalate exposure, DNA methylation of TSLP, and childhood allergy.Clin Epigenetics. 2021 Apr 9;13(1):76. doi: 10.1186/s13148-021-01061-1. Clin Epigenetics. 2021. PMID: 33836808 Free PMC article.
-
Association of Endocrine Disrupting Chemicals With the Metabolic Syndrome Among Women in the Multiethnic Cohort Study.J Endocr Soc. 2023 Nov 17;7(12):bvad136. doi: 10.1210/jendso/bvad136. eCollection 2023 Nov 2. J Endocr Soc. 2023. PMID: 38024651 Free PMC article.
-
Temporal Trends of Urinary Phthalate Concentrations in Two Populations: Effects of REACH Authorization after Five Years.Int J Environ Res Public Health. 2018 Sep 6;15(9):1950. doi: 10.3390/ijerph15091950. Int J Environ Res Public Health. 2018. PMID: 30200671 Free PMC article.
-
Bisphenols and phthalates: Plastic chemical exposures can contribute to adverse cardiovascular health outcomes.Birth Defects Res. 2020 Oct;112(17):1362-1385. doi: 10.1002/bdr2.1752. Epub 2020 Jul 21. Birth Defects Res. 2020. PMID: 32691967 Free PMC article. Review.
-
Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000.Environ Health Perspect. 2004 Mar;112(3):331-8. doi: 10.1289/ehp.6723. Environ Health Perspect. 2004. PMID: 14998749 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources